This case report highlights Tanovea CA1 as an effective treatment for a patient who had failed multiple chemotherapy protocols for the treatment of lymphoma. When the gold standard CHOP protocol and rescue mechlorethamine were not effective at inducing and maintaining remission, Tanovea became a ...
Our data suggest that such inhibitors may be efficacious and sufficient in treatment of lymphoma and leukemia by direct inhibition of DNA synthesis. In conclusion, we propose a model where c-Myc-dependent Txnip downregulation by T-cell activation is critical for release of active Trx1 that in ...
Asthma in the UK biobank was defined as ICD10 diagnoses in fields 41202 or 41204, including anyone of J45.0, J45.1, J45.8, J45.9, and J46 and/or self-reported by the non-cancer illness code, self-reported during verbal interview (data-field 20002) with a code for asthma (1111). Ice...
“Those who receive the Novartis product very often are back in the hospital that day because of CRS risk,” Silver said. “The sicker patients with lymphoma and pediatric ALL are already in the hospital anyway, and infusion happens as an extension of their previous hospital...
Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituxima... PURPOSE: The therapeutic strategy for relapsed or refractory patients with diffuse large B-cell lymphoma (DLBL) remains challenging yet. Salvage ...
2507 Accesses 10 Altmetric 1 Mention Explore all metrics Abstract Introduction Chimeric antigen receptor T-cell (CAR T) therapies have transformed diffuse large B-cell lymphoma (DLBCL) treatment. It is important to better understand their use in Medicare Fee-for-Service (FFS) patients, who often ...